These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3318431)

  • 21. Evaluation of nabumetone in the treatment of active adult rheumatoid arthritis.
    Lanier BG; Turner RA; Collins RL; Senter RG
    Am J Med; 1987 Oct; 83(4B):40-3. PubMed ID: 3318427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nabumetone in the treatment of skin and soft tissue injury.
    Jenner PN
    Am J Med; 1987 Oct; 83(4B):101-6. PubMed ID: 3318420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of nabumetone compared with naproxen on platelet aggregation in patients with rheumatoid arthritis.
    Knijff-Dutmer EA; Martens A; vd Laar MA
    Ann Rheum Dis; 1999 Apr; 58(4):257-9. PubMed ID: 10364907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety experience with nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis.
    Eversmeyer W; Poland M; DeLapp RE; Jensen CP
    Am J Med; 1993 Aug; 95(2A):10S-18S. PubMed ID: 8356997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in the elderly.
    Morgan GJ; Poland M; DeLapp RE
    Am J Med; 1993 Aug; 95(2A):19S-27S. PubMed ID: 8356998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nabumetone therapy of osteoarthritis. A six-week, placebo-controlled study.
    Blechman WJ
    Am J Med; 1987 Oct; 83(4B):70-3. PubMed ID: 3318432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double-blind crossover study of nabumetone versus naproxen in the treatment of osteoarthritis.
    Verbruggen LA; Cytryn E; Pintens H
    J Int Med Res; 1982; 10(4):214-8. PubMed ID: 7117678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind, comparative study of diflunisal and naproxen in the treatment of rheumatoid arthritis.
    Devereaux MD; Douglas WA
    Eur J Rheumatol Inflamm; 1983; 6(3):274-8. PubMed ID: 6391932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety evaluation of nabumetone in United States clinical trials.
    Jackson RE; Mitchell FN; Brindley DA
    Am J Med; 1987 Oct; 83(4B):115-20. PubMed ID: 3318422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double-blind crossover study of nabumetone versus naproxen in the treatment of osteoarthritis of the knee and hip.
    Ginsberg F; Famaey JP
    J Int Med Res; 1982; 10(4):209-13. PubMed ID: 7117677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis.
    Hedner T; Samulesson O; Währborg P; Wadenvik H; Ung KA; Ekbom A
    Drugs; 2004; 64(20):2315-43; discussion 2344-5. PubMed ID: 15456329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the efficacy and safety of oxaprozin and nabumetone in the treatment of patients with osteoarthritis of the knee.
    Weaver A; Rubin B; Caldwell J; McMahon FG; Lee D; Makarowski W; Offenberg H; Sack M; Sikes D; Trapp R
    Clin Ther; 1995; 17(4):735-45. PubMed ID: 8565037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and improved safety--a new anti-arthritic agent.
    Irani M
    Eur J Rheumatol Inflamm; 1991; 11(3):43-9. PubMed ID: 1365480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The long-term U.S. study--a report on outcome and tolerance.
    Fleischmann R
    Eur J Rheumatol Inflamm; 1991; 11(3):50-3. PubMed ID: 1365481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. German drug monitoring studies with nabumetone.
    Stroehmann I; Fedder M; Zeidler H
    Drugs; 1990; 40 Suppl 5():38-42. PubMed ID: 2081491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of the efficacy and safety of nabumetone and diclofenac sodium in the treatment of patients with rheumatoid arthritis].
    Zhonghua Yi Xue Za Zhi; 2001 May; 81(9):557-60. PubMed ID: 11809123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nabumetone. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in rheumatic diseases.
    Friedel HA; Todd PA
    Drugs; 1988 May; 35(5):504-24. PubMed ID: 3293969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review of the experience with nabumetone in clinical trials outside of the United States.
    Jenner PN; Johnson ES
    Am J Med; 1987 Oct; 83(4B):110-4. PubMed ID: 3318421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of a six-month study comparing the safety and efficacy of nabumetone and aspirin in the treatment of osteoarthritis.
    Mullen BJ
    Am J Med; 1987 Oct; 83(4B):74-7. PubMed ID: 3318433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multicenter study of nabumetone and diclofenac SR in patients with osteoarthritis.
    Bellamy N; Bensen WG; Beaulieu A; Siminovitch KA; Kraag GR; Lussier A; Ahmad S; Khanna VN; Davis P; Bell MJ
    J Rheumatol; 1995 May; 22(5):915-20. PubMed ID: 8587082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.